A Novel Treatment Strategy for Patients with Intermediate-Stage HCC Who Are Not Suitable for TACE: Upfront Systemic Therapy Followed by Curative Conversion

Liver Cancer
Source: Liver Cancer - Category: Cancer & Oncology Source Type: research